Por: RTTNews Health May 27, 2023
Biotechnology company Novavax, Inc. () announced Friday that Nuvaxovid (NVX-CoV2373) has been recommended for full Marketing Authorization (MA) for use as a primary series in individuals aged 12 and older and as a booster in individuals aged 18 and older for the prevention of COVID-19 in the European Union (EU).This authorization is based on a positive opinion issued by the Committee for Medicinal Products for Human Use (CHMP) of the European... + full article
RTTNews USA Health May 12, 2023
Novavax, Inc. () announced Friday that the Singapore Health Sciences Authority (HSA) has granted extended interim authorization and the Ministry of Health has included Nuvaxovid (NVX-CoV2373) into the National Vaccination Program as a non-mRNA option for adolescents aged 12... + más
FDA Authorizes Novavax's Covid Shots as Mix-And-Match Booster to Pfizer Or Moderna | NBC 6 South Florida
FDA authorizes Novavax's Covid shots as mix-and-match booster to Pfizer or Moderna | CNBC
ABC News USA Business May 09, 2023
Novavax is cutting about a quarter of its global workforce as the COVID-19 vaccine maker seeks to slash expenses while dealing with uncertain future revenue.The company said Tuesday that it expects to trim next year’s costs for research and development as well as selling,... + más
Forbes USA Tech October 22, 2022
The U.S. Food and Drug Administration (FDA) has just extended the emergency use authorization (EUA) ... [+] for Novavax’s adjuvanted (NVX-CoV2373) Covid-19 vaccine to now include a first booster dose for those 18 years and older. (Photo by Matt McClain/The Washington Post via... + más
CNBC USA Health October 19, 2022
In this articleA healthcare worker prepares a dose of the Novavax Covid-19 vaccine at a pharmacy in Schwenksville, Pennsylvania, US, on Monday, Aug. 1, 2022.Hannah Beier Bloomberg Getty ImagesThe Food and Drug Administration has authorized 's Covid boosters for adults in... + más
Moderna vs. Pfizer: Is it OK to mix and match the updated COVID-19 booster shots? | PennLive
NBC 6 South Florida USA World October 19, 2022
Hannah Beier Bloomberg Getty Images The Food and Drug Administration has authorized 's Covid boosters for adults in the U.S., including for people who received Pfizer's or Moderna's shots as their primary series. The authorization of Novavax's booster could... + más
Forbes USA Tech October 13, 2022
On September 12, the European Commission authorized the use of the Nuvaxovid Covid-19 vaccine as ... [+] both a homologous and heterologous booster for adults 18 years of age and older. (Photo by Patrick van Katwijk/Getty Images)Getty Images The Barenaked Ladies may have sung,... + más
Omicron-specific vaccine boosters get FDA sign-off | The Verge
CDC recommends Covid omicron booster shots for kids as young as 5 years old | CNBC
RTTNews USA Health September 24, 2022
Biotechnology company Novavax, Inc. () announced Friday that the Taiwan Food and Drug Administration (TFDA) has granted expanded emergency use authorization (EUA) for Nuvaxovid (NVX-CoV2373) COVID-19 vaccine for active immunization to prevent disease 2019 (COVID-19) caused by... + más
FDA Updates COVID-19 Test Policy; Asks Developers To Seek Premarket Review Pathways | RTTNews
About iurex | Privacy Policy | Disclaimer |